Literature DB >> 17328785

TRAF1 regulates recruitment of lymphocytes and, to a lesser extent, neutrophils, myeloid dendritic cells and monocytes to the lung airways following lipopolysaccharide inhalation.

Michiko K Oyoshi1, Robert Barthel, Erdyni N Tsitsikov.   

Abstract

Inhaled lipopolysaccharide (LPS) induces an inflammatory response that may contribute to the pathogenesis of asthma and other airway diseases. Here we investigate the role of tumour necrosis factor (TNF) receptor-associated factor 1 (TRAF1) in leucocyte recruitment using a model of LPS-induced lung inflammation in mice. TRAF1(-/-) mice are completely deficient in the recruitment of lymphocytes to the lower respiratory tract after inhalation of LPS. Although TRAF1(-/-) mice display normal early accumulation of neutrophils, dendritic cells and monocytes in the alveolar airspace, they have a significantly reduced recruitment of these cells by 24 hr after inhalation of LPS when compared to wild-type (WT) mice. Despite normal expression of the pro-inflammatory cytokines TNF, interleukin-1 (IL-1) and IL-6 after LPS treatment, TRAF1(-/-) mice displayed decreased expression of intercellular adhesion molecule 1, vascular cell adhesion molecule 1, CCL17 and CCL20 in the lungs, when compared to LPS-treated WT mice. These results suggest that TRAF1 facilitates LPS-induced leucocyte recruitment into the lung airways by augmenting the expression of chemokines and adhesion molecules. Mice lacking TNF receptor 1 (TNFR1) but not TNFR2 show a phenotype similar to the TRAF1(-/-) mice, suggesting that TRAF1 may act downstream of TNFR1. Significantly, we use bone marrow chimeras to demonstrate that expression of TRAF1 by cells resident in the lungs, but not by circulating leucocytes, is necessary for efficient LPS-induced recruitment of leucocytes to the lung airways.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17328785      PMCID: PMC2265890          DOI: 10.1111/j.1365-2567.2006.02499.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  57 in total

1.  Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes.

Authors:  Olivier Micheau; Jürg Tschopp
Journal:  Cell       Date:  2003-07-25       Impact factor: 41.582

Review 2.  Chemokine receptors and leukocyte trafficking in the mucosal immune system.

Authors:  Ifor R Williams
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 3.  Something old, something new: indoor endotoxin, allergens and asthma.

Authors:  Andrew H Liu
Journal:  Paediatr Respir Rev       Date:  2004       Impact factor: 2.726

Review 4.  Inflammatory response to infectious pulmonary injury.

Authors:  C Delclaux; E Azoulay
Journal:  Eur Respir J Suppl       Date:  2003-08

5.  Epstein-Barr virus latent membrane protein 1 activates nuclear factor-kappa B in human endothelial cells and inhibits apoptosis.

Authors:  Anming Xiong; Regina H Clarke-Katzenberg; Glenn Valenzuela; Kenneth M Izumi; Maria T Millan
Journal:  Transplantation       Date:  2004-07-15       Impact factor: 4.939

Review 6.  Systemic response to pneumonia in the critically ill patient.

Authors:  Alan S Multz; Rubin Cohen
Journal:  Semin Respir Infect       Date:  2003-06

7.  In situ localization of TNFalpha/beta, TACE and TNF receptors TNF-R1 and TNF-R2 in control and LPS-treated lung tissue.

Authors:  M Ermert; C Pantazis; H-R Duncker; F Grimminger; W Seeger; L Ermert
Journal:  Cytokine       Date:  2003-05       Impact factor: 3.861

Review 8.  Chemokines in lymphocyte trafficking and intestinal immunity.

Authors:  Eric J Kunkel; Daniel J Campbell; Eugene C Butcher
Journal:  Microcirculation       Date:  2003-06       Impact factor: 2.628

9.  Respiratory epithelial cells regulate lung inflammation in response to inhaled endotoxin.

Authors:  Shawn J Skerrett; H Denny Liggitt; Adeline M Hajjar; Robert K Ernst; Samuel I Miller; Christopher B Wilson
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2004-03-26       Impact factor: 5.464

10.  Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells.

Authors:  Lynne Armstrong; Andrew R L Medford; Kay M Uppington; John Robertson; Ian R Witherden; Teresa D Tetley; Ann B Millar
Journal:  Am J Respir Cell Mol Biol       Date:  2004-03-25       Impact factor: 6.914

View more
  8 in total

1.  Association of TRAF1/C5 Locus Polymorphisms with Epilepsy and Clinical Traits in Mexican Patients with Neurocysticercosis.

Authors:  Marcela Villegas; Edda Sciutto; Marcos Rosetti; Agnes Fleury; Gladis Fragoso
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

2.  Determination of genetic predisposition to patent ductus arteriosus in preterm infants.

Authors:  John M Dagle; Nathan T Lepp; Margaret E Cooper; Kendra L Schaa; Keegan J P Kelsey; Kristin L Orr; Diana Caprau; Cara R Zimmerman; Katherine M Steffen; Karen J Johnson; Mary L Marazita; Jeffrey C Murray
Journal:  Pediatrics       Date:  2009-04       Impact factor: 7.124

3.  TRAF molecules in inflammation and inflammatory diseases.

Authors:  Almin I Lalani; Sining Zhu; Samantha Gokhale; Juan Jin; Ping Xie
Journal:  Curr Pharmacol Rep       Date:  2017-12-20

4.  TLR2, but not TLR4, is required for effective host defence against Chlamydia respiratory tract infection in early life.

Authors:  Emma L Beckett; Simon Phipps; Malcolm R Starkey; Jay C Horvat; Kenneth W Beagley; Paul S Foster; Philip M Hansbro
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

Review 5.  The Role of Tumor Necrosis Factor Associated Factors (TRAFs) in Vascular Inflammation and Atherosclerosis.

Authors:  Mark Colin Gissler; Peter Stachon; Dennis Wolf; Timoteo Marchini
Journal:  Front Cardiovasc Med       Date:  2022-02-17

6.  Therapeutic Potential of Combining IL-6 and TNF Blockade in a Mouse Model of Allergic Asthma.

Authors:  Olga A Namakanova; Ekaterina A Gorshkova; Ruslan V Zvartsev; Sergei A Nedospasov; Marina S Drutskaya; Ekaterina O Gubernatorova
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

7.  An altered sputum macrophage transcriptome contributes to the neutrophilic asthma endotype.

Authors:  Michael Fricker; Ling Qin; Stephany Sánchez-Ovando; Jodie L Simpson; Katherine J Baines; Carlos Riveros; Hayley A Scott; Lisa G Wood; Peter Ab Wark; Nazanin Z Kermani; Kian Fan Chung; Peter G Gibson
Journal:  Allergy       Date:  2021-09-28       Impact factor: 14.710

Review 8.  Role of CD40(L)-TRAF signaling in inflammation and resolution-a double-edged sword.

Authors:  Lea Strohm; Henning Ubbens; Thomas Münzel; Andreas Daiber; Steffen Daub
Journal:  Front Pharmacol       Date:  2022-10-04       Impact factor: 5.988

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.